See Johnson & Johnson's analyst price targets ($280) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$265.58
20 analysts in the last 4 months
High: $320 | Low: $260
No recommendations in the last 4 months.
As of the most recent data, JNJ shows a target price of $280. Scroll down for historical charts and peer comparison views.
If Johnson & Johnson moved to the average analyst target of $280, shares would be roughly 6.8% higher than $265.58. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Johnson & Johnson's earnings trajectory.
Besides this target price page, Stockcircle has Johnson & Johnson's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $280) with ownership activity and broader fundamentals.
Johnson & Johnson's target price is $280; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.